On 12 de nov. de 2025, CRMD reported earnings of 1.26 USD per share (EPS) for Q3 25, beating the estimate of 0.65 USD, resulting in a 91.46% surprise. Revenue reached 104.28 milhão, compared to an expected 87.74 milhão, with a 18.84% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of 0.85 USD, with revenue projected to reach 130.07 milhão USD, implying an diminuir of -32.54% EPS, and aumentar of 24.74% in Revenue from the last quarter.
FAQ
What were CorMedix Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CorMedix Inc. reported EPS of $1.26, beating estimates by 91.46%, and revenue of $104.28M, 18.84% above expectations.
How did the market react to CorMedix Inc.'s Q3 2025 earnings?
The stock price moved up 2.06%, changed from $11.19 before the earnings release to $11.42 the day after.
When is CorMedix Inc. expected to report next?
The next earning report is scheduled for 23 de mar. de 2026.
What are the forecasts for CorMedix Inc.'s next earnings report?
Based on 9
analistas, CorMedix Inc. is expected to report EPS of $0.85 and revenue of $130.07M for Q4 2025.